Seaport Therapeutics, Inc. (SPTX)
17.15
-1.00
(-5.51%)
USD |
NASDAQ |
Oct 12, 16:00
17.09
-0.06
(-0.35%)
After-Hours: 20:00
Seaport Therapeutics Total Assets (Quarterly) : 441.68M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 441.68M |
| Date | Value |
|---|---|
| March 31, 2026 | 227.67M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 201.06B |
| Bristol Myers Squibb Co. | 87.63B |
| Harmony Biosciences Holdings, Inc. | 1.373B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.08M |
| Shareholders Equity (Quarterly) | 422.60M |
| Debt to Equity Ratio | 0.0119 |
| Current Ratio | 18.00 |
| Net Debt Paydown Yield | -0.07% |